| UniProt ID | F120B_HUMAN | |
|---|---|---|
| UniProt AC | Q96EK7 | |
| Protein Name | Constitutive coactivator of peroxisome proliferator-activated receptor gamma | |
| Gene Name | FAM120B | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 910 | |
| Subcellular Localization | Nucleus. | |
| Protein Description | Functions as a transactivator of PPARG and ESR1. Functions in adipogenesis through PPARG activation (By similarity).. | |
| Protein Sequence | MGVRGLQGFVGSTCPHICTVVNFKELAEHHRSKYPGCTPTIVVDAMCCLRYWYTPESWICGGQWREYFSALRDFVKTFTAAGIKLIFFFDGMVEQDKRDEWVKRRLKNNREISRIFHYIKSHKEQPGRNMFFIPSGLAVFTRFALKTLGQETLCSLQEADYEVASYGLQHNCLGILGEDTDYLIYDTCPYFSISELCLESLDTVMLCREKLCESLGLCVADLPLLACLLGNDIIPEGMFESFRYKCLSSYTSVKENFDKKGNIILAVSDHISKVLYLYQGEKKLEEILPLGPNKALFYKGMASYLLPGQKSPWFFQKPKGVITLDKQVISTSSDAESREEVPMCSDAESRQEVPMCTGPESRREVPVYTDSEPRQEVPMCSDPEPRQEVPTCTGPESRREVPMCSDPEPRQEVPMCTGPEARQEVPMYTDSEPRQEVPMYTDSEPRQEVPMYTGSEPRQEVPMYTGPESRQEVPMYTGPESRQEVLIRTDPESRQEIMCTGHESKQEVPICTDPISKQEDSMCTHAEINQKLPVATDFEFKLEALMCTNPEIKQEDPTNVGPEVKQQVTMVSDTEILKVARTHHVQAESYLVYNIMSSGEIECSNTLEDELDQALPSQAFIYRPIRQRVYSLLLEDCQDVTSTCLAVKEWFVYPGNPLRHPDLVRPLQMTIPGGTPSLKILWLNQEPEIQVRRLDTLLACFNLSSSREELQAVESPFQALCCLLIYLFVQVDTLCLEDLHAFIAQALCLQGKSTSQLVNLQPDYINPRAVQLGSLLVRGLTTLVLVNSACGFPWKTSDFMPWNVFDGKLFHQKYLQSEKGYAVEVLLEQNRSRLTKFHNLKAVVCKACMKENRRITGRAHWGSHHAGRWGRQGSSYHRTGSGYSRSSQGQPWRDQGPGSRQYEHDQWRRY | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 24 | Ubiquitination | ICTVVNFKELAEHHR EEEEECHHHHHHHHH | 46.76 | - | |
| 33 | Ubiquitination | LAEHHRSKYPGCTPT HHHHHHHCCCCCCCH | 56.26 | - | |
| 103 | Ubiquitination | DKRDEWVKRRLKNNR HHHHHHHHHHHHCCH | 32.64 | - | |
| 120 | Ubiquitination | SRIFHYIKSHKEQPG HHHHHHHHHCCCCCC | 39.06 | - | |
| 145 | Ubiquitination | AVFTRFALKTLGQET HHHHHHHHHHHCCHH | 3.91 | - | |
| 178 | Ubiquitination | NCLGILGEDTDYLIY CCEEECCCCCCEEEE | 55.05 | - | |
| 272 | Phosphorylation | LAVSDHISKVLYLYQ EEEEHHHHHHHHHHH | 17.19 | 28387310 | |
| 294 | Ubiquitination | ILPLGPNKALFYKGM HCCCCCCHHHHCCCC | 49.99 | - | |
| 299 (in isoform 2) | Ubiquitination | - | 34.57 | 21890473 | |
| 299 | Ubiquitination | PNKALFYKGMASYLL CCHHHHCCCCHHHCC | 34.57 | 21890473 | |
| 317 (in isoform 2) | Ubiquitination | - | 43.47 | 21890473 | |
| 317 | Ubiquitination | KSPWFFQKPKGVITL CCCCHHCCCCCEEEE | 43.47 | 21890473 | |
| 319 | Ubiquitination | PWFFQKPKGVITLDK CCHHCCCCCEEEECC | 73.22 | - | |
| 322 | Ubiquitination | FQKPKGVITLDKQVI HCCCCCEEEECCEEE | 4.28 | 21890473 | |
| 322 (in isoform 1) | Ubiquitination | - | 4.28 | 21890473 | |
| 326 | Ubiquitination | KGVITLDKQVISTSS CCEEEECCEEEECCC | 49.96 | - | |
| 330 | Phosphorylation | TLDKQVISTSSDAES EECCEEEECCCCCHH | 24.31 | 27732954 | |
| 331 | Phosphorylation | LDKQVISTSSDAESR ECCEEEECCCCCHHH | 22.56 | 24719451 | |
| 332 | Phosphorylation | DKQVISTSSDAESRE CCEEEECCCCCHHHC | 21.30 | 27732954 | |
| 333 | Phosphorylation | KQVISTSSDAESREE CEEEECCCCCHHHCC | 40.71 | 27732954 | |
| 340 | Ubiquitination | SDAESREEVPMCSDA CCCHHHCCCCCCCCH | 51.30 | 21890473 | |
| 340 (in isoform 1) | Ubiquitination | - | 51.30 | 21890473 | |
| 345 | Phosphorylation | REEVPMCSDAESRQE HCCCCCCCCHHHHCC | 33.34 | 28985074 | |
| 368 | Phosphorylation | SRREVPVYTDSEPRQ HHCCCCCCCCCCCCC | 9.96 | 28796482 | |
| 369 | Phosphorylation | RREVPVYTDSEPRQE HCCCCCCCCCCCCCC | 33.03 | 28796482 | |
| 371 | Phosphorylation | EVPVYTDSEPRQEVP CCCCCCCCCCCCCCC | 41.52 | 28796482 | |
| 381 | Phosphorylation | RQEVPMCSDPEPRQE CCCCCCCCCCCCCCC | 50.37 | 21712546 | |
| 391 | Phosphorylation | EPRQEVPTCTGPESR CCCCCCCCCCCCHHH | 28.07 | 24043423 | |
| 393 | Phosphorylation | RQEVPTCTGPESRRE CCCCCCCCCCHHHCC | 59.24 | 24043423 | |
| 397 | Phosphorylation | PTCTGPESRREVPMC CCCCCCHHHCCCCCC | 39.51 | 24043423 | |
| 415 | Sulfoxidation | EPRQEVPMCTGPEAR CCCCCCCCCCCHHHH | 3.74 | 21406390 | |
| 417 | Phosphorylation | RQEVPMCTGPEARQE CCCCCCCCCHHHHHC | 49.90 | 24719451 | |
| 428 | Phosphorylation | ARQEVPMYTDSEPRQ HHHCCCCCCCCCCCC | 11.00 | 28796482 | |
| 429 | Phosphorylation | RQEVPMYTDSEPRQE HHCCCCCCCCCCCCC | 27.14 | 28796482 | |
| 431 | Phosphorylation | EVPMYTDSEPRQEVP CCCCCCCCCCCCCCC | 41.52 | 28796482 | |
| 440 | Phosphorylation | PRQEVPMYTDSEPRQ CCCCCCCCCCCCCCC | 11.00 | 28796482 | |
| 441 | Phosphorylation | RQEVPMYTDSEPRQE CCCCCCCCCCCCCCC | 27.14 | 28796482 | |
| 443 | Phosphorylation | EVPMYTDSEPRQEVP CCCCCCCCCCCCCCC | 41.52 | 28796482 | |
| 452 | Phosphorylation | PRQEVPMYTGSEPRQ CCCCCCCCCCCCCCC | 11.24 | 21945579 | |
| 453 | Phosphorylation | RQEVPMYTGSEPRQE CCCCCCCCCCCCCCC | 28.16 | 21945579 | |
| 455 | Phosphorylation | EVPMYTGSEPRQEVP CCCCCCCCCCCCCCC | 36.31 | 21945579 | |
| 464 | Phosphorylation | PRQEVPMYTGPESRQ CCCCCCCCCCCCHHC | 11.50 | 21945579 | |
| 465 | Phosphorylation | RQEVPMYTGPESRQE CCCCCCCCCCCHHCC | 39.75 | 21945579 | |
| 476 | Phosphorylation | SRQEVPMYTGPESRQ HHCCCCCCCCCCHHC | 11.50 | 21945579 | |
| 477 | Phosphorylation | RQEVPMYTGPESRQE HCCCCCCCCCCHHCE | 39.75 | 21945579 | |
| 500 | Phosphorylation | SRQEIMCTGHESKQE HCCEEEECCCCCCCC | 24.96 | 29083192 | |
| 504 | Phosphorylation | IMCTGHESKQEVPIC EEECCCCCCCCCCCC | 33.68 | 29083192 | |
| 553 | Sumoylation | MCTNPEIKQEDPTNV HHCCCCCCCCCCCCC | 46.07 | - | |
| 565 | Sumoylation | TNVGPEVKQQVTMVS CCCCHHHHHEEEEEC | 33.09 | - | |
| 578 | Ubiquitination | VSDTEILKVARTHHV ECCHHHHHHHHHCCC | 39.24 | - | |
| 670 | Phosphorylation | LVRPLQMTIPGGTPS HCCEEEEECCCCCCC | 15.85 | - | |
| 675 | Phosphorylation | QMTIPGGTPSLKILW EEECCCCCCCEEEEE | 18.67 | - | |
| 677 | Phosphorylation | TIPGGTPSLKILWLN ECCCCCCCEEEEEEC | 41.98 | - | |
| 764 | Phosphorylation | LVNLQPDYINPRAVQ HHCCCCCCCCHHHHH | 14.85 | 28152594 | |
| 781 | Phosphorylation | SLLVRGLTTLVLVNS HHHHHHHHHEEEECC | 22.40 | - | |
| 788 | Phosphorylation | TTLVLVNSACGFPWK HHEEEECCCCCCCCC | 19.91 | - | |
| 813 | Ubiquitination | DGKLFHQKYLQSEKG CCCEEHHHHHHCCCC | 39.08 | 21890473 | |
| 836 | Ubiquitination | QNRSRLTKFHNLKAV CCHHHHHHHHCHHHH | 49.58 | 21890473 | |
| 836 | Ubiquitination | QNRSRLTKFHNLKAV CCHHHHHHHHCHHHH | 49.58 | - | |
| 836 (in isoform 1) | Ubiquitination | - | 49.58 | 21890473 | |
| 841 | Acetylation | LTKFHNLKAVVCKAC HHHHHCHHHHHHHHH | 44.44 | 25953088 | |
| 841 | Ubiquitination | LTKFHNLKAVVCKAC HHHHHCHHHHHHHHH | 44.44 | - | |
| 846 | Ubiquitination | NLKAVVCKACMKENR CHHHHHHHHHHHHCC | 32.77 | - | |
| 863 | Phosphorylation | TGRAHWGSHHAGRWG CCCCCCCCCCCCCCC | 13.60 | 24719451 | |
| 868 | Methylation | WGSHHAGRWGRQGSS CCCCCCCCCCCCCCC | 33.20 | - | |
| 871 | Methylation | HHAGRWGRQGSSYHR CCCCCCCCCCCCCCC | 30.63 | - | |
| 874 | Phosphorylation | GRWGRQGSSYHRTGS CCCCCCCCCCCCCCC | 21.27 | 26437602 | |
| 878 | Methylation | RQGSSYHRTGSGYSR CCCCCCCCCCCCCCC | 32.33 | - | |
| 881 | Phosphorylation | SSYHRTGSGYSRSSQ CCCCCCCCCCCCCCC | 33.66 | - | |
| 885 | Methylation | RTGSGYSRSSQGQPW CCCCCCCCCCCCCCC | 31.66 | 24129315 | |
| 893 | Methylation | SSQGQPWRDQGPGSR CCCCCCCCCCCCCCC | 32.81 | - |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of F120B_HUMAN !! | ||||||
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of F120B_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of F120B_HUMAN !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
| RL30_HUMAN | RPL30 | physical | 21988832 |
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...